AQB
AquaBounty Technologies, Inc.NASDAQConsumer DefensiveAs of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
-1.87
P/S
0.00
EV/EBITDA
314.51
DCF Value
$128.42
FCF Yield
-580827.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-180.7%
ROA
-0.2%
ROIC
-0.2%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $-18.49B | $-3.64 |
| FY 2025 | $0.00 | $-18.49B | $-4.77 |
| Q3 2025 | $0.00 | $-1.4M | $-0.36 |
| Q2 2025 | $0.00 | $-3.4M | $-0.87 |
Analyst Ratings
View AllConsensus
Hold
Target (Consensus)
$3.00
Target (Median)
$3.00
Target Range
$2.00 - $4.00
Trading Activity
Insider Trades
View AllCompany Info
Sector
Consumer Defensive
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.30
AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.